Last week, the British Embassy in Israel led a excessive‑degree delegation of ten main Israeli specialists in genomics and biodata to the UK. The delegation included senior researchers, heads of genomics labs in universities and hospitals, entrepreneurs and enterprise capital.
The go to featured a tailored programme together with a tour to London’s Knowledge Quarter – one of many world’s densest clusters of analysis and scientific establishments. Anchored by organizations such because the Francis Crick Institute and University College London, the Knowledge Quarter has grow to be a powerhouse for all times sciences innovation. Its distinctive focus of educational, medical and business companions allows speedy collaboration, entry to world-class analysis infrastructure, and a vibrant ecosystem supporting the interpretation of scientific discoveries into real-world well being options.
1 View gallery
Top Israeli genomics and biodata specialists go to the UK to increase scientific and innovation partnerships
(Photo: Omri Dagan)
The delegation included main specialists in genomics, genome modifying, immunology and AI‑pushed translational drugs. Among the outstanding researchers was Prof. Yifat Merbl of the Weizmann Institute of Science, not too long ago named in Nature’s “10 People Who Shaped Science in 2025” for her groundbreaking discoveries on the immune system.
An night reception marked the robust and rising analysis and expertise collaboration between the 2 nations in slicing‑edge life sciences, bringing collectively key companions from the UK and Israel to focus on shared priorities, rising alternatives and the increasing impression of genomics and biodata on healthcare innovation.
The UK and Israel each excel in genomics and biodata. Bringing collectively the complementary strengths of each nations allows scientific breakthroughs, accelerates medical translation and creates new alternatives for joint analysis, innovation and commercialization that may impression world well being outcomes.
British Chargé d’Affaires to Israel Thomas Phipps: “Genomics and the wider life sciences sector sit at the heart of the UK’s Industrial Strategy, supported by substantial national investment in genomics, health data and research infrastructure. We are glad to support UK – Israel collaboration in these fields, where joint innovation can deliver significant benefit for both countries.”
Head of Science and Technology on the British Embassy in Israel, Shira Lanir: “We are proud to lead this delegation of top Israeli genomics and biodata experts to the UK. Both the UK and Israel are global leaders in life sciences, and by combining strengths and capabilities, we can accelerate the translation of cutting-edge research into real-world health innovation solutions.”